Vitalograph and Thorasys Unite for Respiratory Innovation
At a recent conference, Vitalograph and Thorasys announced a strategic partnership focused on enhancing respiratory diagnostics. This collaboration introduces the tremoflo® C2 oscillometer, which significantly expands the existing range of respiratory diagnostic tools.
Introducing the Tremoflo® C2 Oscillometer
This partnership officially unveils the tremoflo® C2 portable oscillometer, increasing access to innovative Airwave Oscillometry System (AOS) technology for various patient demographics. It’s an exciting development for clinicians seeking to employ advanced diagnostic tools.
Benefits for Healthcare Providers
With this integration, Vitalograph's U.S. customers can now leverage the oscillometry technology fully integrated into their respiratory diagnostic offerings. This means that patients who may struggle with traditional spirometry tests can benefit from the simplicity of oscillometry.
A Step Forward in Respiratory Care
Doreen Miao, the Vice President of Marketing and Strategic Development at Thorasys, expressed excitement about the launch. She stated that the tremoflo® C2 is a crucial enhancement to pulmonary function testing (PFT). The device promotes early detection and continuous monitoring of respiratory diseases, which is critical for successful treatment.
Enhancing Integration Within the Industry
This partnership particularly benefits Morgan Scientific, Vitalograph's U.S. division focused on specialty pulmonary function solutions. The integration of oscillometry into their suite of diagnostic tools will allow for a more streamlined and effective respiratory care process.
Client Insights from Morgan Scientific
Gareth Morgan, President of Morgan Scientific, emphasized how this integration will help clients who face challenges with traditional spirometry. By offering the compact tremoflo® C2, they aim to deliver enhanced solutions to their existing clientele.
Innovating for Better Patient Care
The collaboration not only aims to improve respiratory diagnostics but also establishes a foundation for ongoing research and technological advancement. Along with the tremoflo® C-100 oscillometer, the new device provides healthcare professionals with a robust toolkit for assessing and managing lung health.
About Our Partners
- Vitalograph: A leader in respiratory diagnostic solutions, catering to both clinical practice and research settings.
- Thorasys: Renowned for its portable oscillometry technologies, providing precision and reliability in lung function assessment.
- Morgan Scientific: A prominent provider of advanced pulmonary function testing solutions across the United States, now an integral part of Vitalograph.
Contact Information
For further inquiries, reach out to:
Laura Colleran
+ 353 (0)89 4727860
For media inquiries, please reach out to Laura for information.
Frequently Asked Questions
What is the tremoflo® C2 oscillometer?
The tremoflo® C2 is a portable oscillometer that facilitates non-invasive respiratory diagnostics, making it easier for patients who face challenges with standard tests.
How does this partnership benefit healthcare providers?
It provides healthcare providers with integrated oscillometry technology, enhancing their diagnostic capabilities and patient care options.
Who are the key players in this partnership?
The key players include Vitalograph, Thorasys, and Morgan Scientific, each bringing expertise in respiratory health technologies.
Why is oscillometry significant in respiratory diagnostics?
Oscillometry allows for early diagnosis and ongoing monitoring of respiratory conditions, which can lead to better outcomes for patients.
Where can I find more information about these companies?
For more details, you may contact Laura Colleran directly for insights into their offerings and developments in respiratory health.
